Pharma News

China National Medical Products Administration (NMPA) has granted acceptance and priority review for the new drug application (NDA) for HUTCHMED’s ORPATHYS (savolitinib) and ...

Testing Services Market Outlook, 2025-2035 - Dominated by Charles River Laboratories Int'l, Eurofins Scientific, SGS, WuXi AppTec, and Pace Analytical Services

The Indian Institute of Technology (IIT) Guwahati and the Bose Institute Kolkata research team have developed an advanced injectable hydrogel designed to release anti-cancer therapies to tumou...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise.

The Texas-based company has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities.  XBiotech’s stock price has taken a hit after it announced ...

Haemophilia is a rare condition that affects the blood’s ability to clot.

Tirzepatide (Zepbound; Eli Lilly) is now approved for the treatment of moderate-to-severe obstructive sleep apnea (OSA) with obesity, the Food and Drug Administration announced late la...

In a press release posted on FDA’s website, Endo USA, Inc. announced it was voluntarily recalling all lots of Adrenalin Chloride Solution (EPINEPHrine nasal solution, USP) 30 mg/30 mL (1...

The FDA granted fast track designation (FTD) to a multivalent toxoid vaccine candidate from LimmaTech, LBT-SA7, which is designed to prevent skin and soft tissue infections (SSTIs) cau...

Two clinical trials by Merck and GSK both failed on their key secondary endpoints of overall survival in ovarian cancer. Perhaps PD-1 inhibitors just aren’t for ovarian cancer after all.

Aadi Bioscience has rebooted its operations, transforming from a commercial business into a preclinical biotech by offloading its approved product and licensing antibody-drug conjugates (ADCs)...

Ozempic maker Novo Nordisk A/S took two large steps toward meeting demand for its blockbuster drugs, committing $1.2 billion to build a new factory in Denmark shortly after it got the green light for ...